Product Type
Condition
Binding
Collectible Attributes
Free Shipping
Seller Location
Seller Rating
Published by Karger, S. Karger Apr 2023, 2023
ISBN 10: 3318072494ISBN 13: 9783318072495
Seller: Smartbuy, Einbeck, Germany
Book
Taschenbuch. Condition: Neu. Neuware - Non-small cell lung cancer (NSCLC) is one of two main types of lung cancer. Some lung cancers spread to other parts of the body before they are diagnosed. A cancer that has spread is called 'metastatic'. New lung cancer treatments are being developed that directly target the gene mutations that control how cancers grow and spread. The most important gene mutations in cancer are called 'driver mutations'. In NSCLC, this includes KRAS mutations, which can be used as targets for treatment. There are new treatments designed for lung cancers with a KRAS mutation that are already available. And more are being developed. Treatments in development are tested in clinical trials. There are several different phases of clinical trials that people with cancer can take part in. This booklet aims to help patients with NSCLC understand their options so that they can talk to their doctors, nurses, and medical team about their cancer and its treatment. Table of Contents: -What is non-small cell lung cancer -How can lung cancer develop -What is metastatic NSCLC -More about genes and cancer -Oncogenes and cancer -Driver mutations and biomarkers -How your doctor knows your cancer is KRAS-positive -More about KRAS -What does having a KRAS-positive cancer mean for me -Talking to your doctor about your treatment -About clinical trials and research -Finding further information and support 36 pp. Englisch.
Published by S. Karger Karger Apr 2023, 2023
ISBN 10: 3318070211ISBN 13: 9783318070217
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Book
Taschenbuch. Condition: Neu. Neuware -Written for all members of the multidisciplinary breast cancer care team, and for everyone who wishes to know about breast cancer, this concise resource will aid understanding of the risk of developing breast cancer, the essentials of diagnosis and preoperative assessment, and the current approach to treatment and follow-up, with a focus on how each mode of treatment can be optimized to match the individual patient's needs based on high-quality evidence. Table of Contents: -Etiopathophysiology and risk -Diagnosis -Staging and clinical status -Locoregional treatment -Adjuvant therapy -Survivorship 106 pp. Englisch.
Published by S. Karger Karger Apr 2023, 2023
ISBN 10: 3318072478ISBN 13: 9783318072471
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Book
Taschenbuch. Condition: Neu. Neuware -'Fast Facts: Managing Immune-Related Adverse Events in Oncology, 2nd edition', provides an overview of immuno-oncology and an update on immune checkpoint inhibitors and their associated toxicities, alongside the principles of diagnosing and managing immune-related adverse events, important nursing care considerations and a set of convenient management summaries for quick reference. As such, it is essential reading for all members of the cancer care team. 140 pp. Englisch.
Published by Karger, S. Karger Apr 2023, 2023
ISBN 10: 3318072478ISBN 13: 9783318072471
Seller: AHA-BUCH GmbH, Einbeck, Germany
Book
Taschenbuch. Condition: Neu. Neuware - 'Fast Facts: Managing Immune-Related Adverse Events in Oncology, 2nd edition', provides an overview of immuno-oncology and an update on immune checkpoint inhibitors and their associated toxicities, alongside the principles of diagnosing and managing immune-related adverse events, important nursing care considerations and a set of convenient management summaries for quick reference. As such, it is essential reading for all members of the cancer care team.
Published by Karger, S. Karger Apr 2023, 2023
ISBN 10: 3318070211ISBN 13: 9783318070217
Seller: AHA-BUCH GmbH, Einbeck, Germany
Book
Taschenbuch. Condition: Neu. Neuware - Written for all members of the multidisciplinary breast cancer care team, and for everyone who wishes to know about breast cancer, this concise resource will aid understanding of the risk of developing breast cancer, the essentials of diagnosis and preoperative assessment, and the current approach to treatment and follow-up, with a focus on how each mode of treatment can be optimized to match the individual patient's needs based on high-quality evidence. Table of Contents: -Etiopathophysiology and risk -Diagnosis -Staging and clinical status -Locoregional treatment -Adjuvant therapy -Survivorship.